These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32935235)

  • 21. Bulk and dispersed aqueous behaviour of an endogenous lipid, selachyl alcohol: Effect of Tween 80 and Pluronic F127 on nanostructure.
    Younus M; Hawley A; Boyd BJ; Rizwan SB
    Colloids Surf B Biointerfaces; 2018 Sep; 169():135-142. PubMed ID: 29758539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
    Lee KW; Porter CJ; Boyd BJ
    J Pharm Sci; 2013 Feb; 102(2):565-78. PubMed ID: 23242691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
    Yeap YY; Trevaskis NL; Porter CJ
    Mol Pharm; 2013 Jul; 10(7):2601-15. PubMed ID: 23697606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.
    Khan J; Rades T; Boyd BJ
    Mol Pharm; 2016 Nov; 13(11):3783-3793. PubMed ID: 27631273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the Mechanism of Enzyme-Induced Formation of Lyotropic Liquid Crystalline Nanoparticles.
    Hong L; Salentinig S; Hawley A; Boyd BJ
    Langmuir; 2015 Jun; 31(24):6933-41. PubMed ID: 26029994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
    Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of digestion is essential to the understanding of milk as a drug delivery system for poorly water soluble drugs.
    Boyd BJ; Salim M; Clulow AJ; Ramirez G; Pham AC; Hawley A
    J Control Release; 2018 Dec; 292():13-17. PubMed ID: 30359667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo.
    Sasahara K; Shimokawa Y; Hirao Y; Koyama N; Kitano K; Shibata M; Umehara K
    Drug Metab Dispos; 2015 Aug; 43(8):1267-76. PubMed ID: 26055620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chase Dosing of Lipid Formulations to Enhance Oral Bioavailability of Nilotinib in Rats.
    Koehl NJ; Holm R; Kuentz M; Griffin BT
    Pharm Res; 2020 Jun; 37(7):124. PubMed ID: 32524365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis.
    Sasaki T; Svensson EM; Wang X; Wang Y; Hafkin J; Karlsson MO; Mallikaarjun S
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0160821. PubMed ID: 34843388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies.
    Sahbaz Y; Nguyen TH; Ford L; McEvoy CL; Williams HD; Scammells PJ; Porter CJH
    Mol Pharm; 2017 Nov; 14(11):3669-3683. PubMed ID: 28954512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
    Kaukonen AM; Boyd BJ; Charman WN; Porter CJ
    Pharm Res; 2004 Feb; 21(2):254-60. PubMed ID: 15032306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison across Three Hybrid Lipid-Based Drug Delivery Systems for Improving the Oral Absorption of the Poorly Water-Soluble Weak Base Cinnarizine.
    Joyce P; Yasmin R; Bhatt A; Boyd BJ; Pham A; Prestidge CA
    Mol Pharm; 2017 Nov; 14(11):4008-4018. PubMed ID: 28950059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion.
    Salim M; Fraser-Miller SJ; Be Rziņš KR; Sutton JJ; Ramirez G; Clulow AJ; Hawley A; Beilles S; Gordon KC; Boyd BJ
    Mol Pharm; 2020 Mar; 17(3):885-899. PubMed ID: 32011151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
    Lee KW; Nguyen TH; Hanley T; Boyd BJ
    Int J Pharm; 2009 Jan; 365(1-2):190-9. PubMed ID: 18790030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.
    Williams HD; Trevaskis NL; Yeap YY; Anby MU; Pouton CW; Porter CJ
    Pharm Res; 2013 Dec; 30(12):2976-92. PubMed ID: 23824582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of liquid crystals with cyclodextrin on the bioavailability of a poorly water-soluble compound, diosgenin, after its oral administration to rats.
    Okawara M; Hashimoto F; Todo H; Sugibayashi K; Tokudome Y
    Int J Pharm; 2014 Sep; 472(1-2):257-61. PubMed ID: 24954725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.